DD202871A5 - Verfahren zur herstellung von sulfiminen - Google Patents
Verfahren zur herstellung von sulfiminen Download PDFInfo
- Publication number
- DD202871A5 DD202871A5 DD82241832A DD24183282A DD202871A5 DD 202871 A5 DD202871 A5 DD 202871A5 DD 82241832 A DD82241832 A DD 82241832A DD 24183282 A DD24183282 A DD 24183282A DD 202871 A5 DD202871 A5 DD 202871A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- general formula
- group
- butoxy
- theory
- yield
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19813129444 DE3129444A1 (de) | 1981-07-25 | 1981-07-25 | "sulfoximine, deren herstellung und diese verbindungen enthaltende arzneimittel" |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD202871A5 true DD202871A5 (de) | 1983-10-05 |
Family
ID=6137766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD82241832A DD202871A5 (de) | 1981-07-25 | 1982-07-21 | Verfahren zur herstellung von sulfiminen |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JPS5824559A (enExample) |
| KR (1) | KR840000491A (enExample) |
| AR (1) | AR230745A1 (enExample) |
| AU (1) | AU556082B2 (enExample) |
| CA (1) | CA1175430A (enExample) |
| CS (1) | CS236488B2 (enExample) |
| DD (1) | DD202871A5 (enExample) |
| DE (2) | DE3129444A1 (enExample) |
| DK (1) | DK329582A (enExample) |
| ES (4) | ES8305333A1 (enExample) |
| FI (1) | FI822550A7 (enExample) |
| GR (1) | GR76181B (enExample) |
| HU (1) | HU188188B (enExample) |
| NO (1) | NO822255L (enExample) |
| PL (1) | PL137725B1 (enExample) |
| PT (1) | PT75297A (enExample) |
| SU (1) | SU1158041A3 (enExample) |
| YU (1) | YU158182A (enExample) |
| ZA (1) | ZA825273B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7863283B2 (en) * | 2008-01-17 | 2011-01-04 | Bayer Schering Pharma Ag | Sulphoximine-substituted quinazoline derivatives as immuno-modulators, their preparation and use as medicaments |
-
1981
- 1981-07-25 DE DE19813129444 patent/DE3129444A1/de not_active Withdrawn
-
1982
- 1982-06-30 NO NO822255A patent/NO822255L/no unknown
- 1982-07-16 SU SU823463928A patent/SU1158041A3/ru active
- 1982-07-20 FI FI822550A patent/FI822550A7/fi not_active Application Discontinuation
- 1982-07-20 YU YU01581/82A patent/YU158182A/xx unknown
- 1982-07-21 DD DD82241832A patent/DD202871A5/de unknown
- 1982-07-21 PL PL1982237600A patent/PL137725B1/pl unknown
- 1982-07-21 AR AR290035A patent/AR230745A1/es active
- 1982-07-22 DK DK329582A patent/DK329582A/da not_active Application Discontinuation
- 1982-07-22 HU HU822373A patent/HU188188B/hu unknown
- 1982-07-22 CS CS825591A patent/CS236488B2/cs unknown
- 1982-07-22 PT PT75297A patent/PT75297A/pt unknown
- 1982-07-23 JP JP57128814A patent/JPS5824559A/ja active Pending
- 1982-07-23 GR GR68840A patent/GR76181B/el unknown
- 1982-07-23 AU AU86378/82A patent/AU556082B2/en not_active Ceased
- 1982-07-23 ZA ZA825273A patent/ZA825273B/xx unknown
- 1982-07-23 ES ES514275A patent/ES8305333A1/es not_active Expired
- 1982-07-23 CA CA000407915A patent/CA1175430A/en not_active Expired
- 1982-07-24 KR KR1019820003316A patent/KR840000491A/ko not_active Ceased
- 1982-12-18 DE DE19823246980 patent/DE3246980A1/de not_active Withdrawn
-
1983
- 1983-01-07 ES ES518826A patent/ES8400410A1/es not_active Expired
- 1983-01-07 ES ES518827A patent/ES518827A0/es active Granted
- 1983-01-07 ES ES518828A patent/ES518828A0/es active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| ES8400412A1 (es) | 1983-10-16 |
| ZA825273B (en) | 1984-03-28 |
| SU1158041A3 (ru) | 1985-05-23 |
| ES8400411A1 (es) | 1983-10-16 |
| AU556082B2 (en) | 1986-10-23 |
| ES518826A0 (es) | 1983-10-16 |
| CS236488B2 (en) | 1985-05-15 |
| AU8637882A (en) | 1983-04-14 |
| PL137725B1 (en) | 1986-07-31 |
| PL237600A1 (en) | 1983-03-28 |
| ES514275A0 (es) | 1983-04-01 |
| FI822550A0 (fi) | 1982-07-20 |
| HU188188B (en) | 1986-03-28 |
| KR840000491A (ko) | 1984-02-22 |
| ES8305333A1 (es) | 1983-04-01 |
| FI822550L (fi) | 1983-01-26 |
| ES8400410A1 (es) | 1983-10-16 |
| JPS5824559A (ja) | 1983-02-14 |
| ES518827A0 (es) | 1983-10-16 |
| FI822550A7 (fi) | 1983-01-26 |
| YU158182A (en) | 1984-08-31 |
| AR230745A1 (es) | 1984-06-29 |
| ES518828A0 (es) | 1983-10-16 |
| PT75297A (fr) | 1982-08-01 |
| DE3246980A1 (de) | 1984-06-20 |
| NO822255L (no) | 1983-01-26 |
| GR76181B (enExample) | 1984-08-03 |
| DE3129444A1 (de) | 1983-02-10 |
| CA1175430A (en) | 1984-10-02 |
| DK329582A (da) | 1983-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0008391B1 (de) | Benzimidazole, deren Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE69730490T2 (de) | Aminoheterocyclische verbindungen als antithrombotisches oder antikoagulierendes mittel | |
| DE69129428T2 (de) | Schwefelderivate von Imidazol, Verfahren zu ihrer Herstellung, Zwischenprodukte, ihre Verwendung als Arzneimittel und sie enthaltende pharmazeutische Zusammensetzungen | |
| EP0497852A1 (de) | Bicyclo-imidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
| DE3132613A1 (de) | Imidazolderivate | |
| WO1991004974A1 (de) | 2-bicyclo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| DE69818041T2 (de) | Cyanoguanidine als zellproliferation inhibitoren | |
| DD284679A5 (de) | Verfahren zur herstellung von adenosin 5'-carboamidderivate | |
| DE3331808A1 (de) | Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten | |
| DE102004028973A1 (de) | Substituierte Tetrahydro-2H-isochinolin-1-on-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament | |
| EP0263352A1 (de) | Neue Imidazo-benzoxazinone, ihre Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| EP0185964B1 (de) | Dihydropyridin-carbonsäureamide, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln | |
| DD263772A5 (de) | Verfahren zur herstellung neuer 1h, 3h-pyrrolo[1,2-c]thiazolderivate | |
| EP0450359B1 (de) | Herbizides Mittel | |
| DE69817810T2 (de) | Cyanoguanidine als zellproliferation inhibitoren | |
| DE4342024A1 (de) | Kombinationspräparate, enthaltend ein Chinoxalin und ein Nukleosid | |
| DE19614542A1 (de) | Neue Carbonsäurederivate, ihre Herstellung und Verwendung | |
| DE69416540T2 (de) | Heterocyclische Verbindungen und pharmazeutische Verwendung | |
| DE69427179T2 (de) | Verfahren zur Herstellung von schwefelhaltigen Imidazolderivaten und erhaltene Zwischenprodukte | |
| DD202871A5 (de) | Verfahren zur herstellung von sulfiminen | |
| DE60202969T2 (de) | Substituierte alkylaminopyridazinonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
| EP0071150B1 (de) | Sulfimine, deren Salze und deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel | |
| LU83744A1 (de) | Neue indolinone,ihre herstellung und ihre verwendung als arzneimittel | |
| DD210453A5 (de) | Verfahren zur herstellung von benzoxazin-2-onen | |
| DE10331500A1 (de) | Neue Acridin-Derivate und deren Verwendung als Arzneimittel |